BXP vs FRT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BXP exhibits a stable but fragile financial health with a Piotroski F-Score of 4/9, while valuation metrics suggest the stock is significantly overpriced. The current price of $57.73 trades at a steep premium to the Graham Number ($35.65) and the Intrinsic Value ($12.18). Severe revenue contraction (-31.90% YoY) and an unsustainable dividend payout ratio of 193.10% indicate a high risk of capital erosion or dividend cuts. Despite bullish analyst targets, the deterministic data and bearish insider activity point toward a value trap.
FRT exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. While the stock trades significantly above its Graham Number ($61.34), it remains below its growth-based intrinsic value of $137.76. However, the outlook is tempered by a dangerously high dividend payout ratio of 95.3% and a severely bearish technical trend (10/100). The synthesis of explosive earnings growth and poor technical momentum suggests a period of consolidation or potential correction despite fundamental strength.
Compare Another Pair
Related Comparisons
BXP vs FRT: Head-to-Head Comparison
This page compares BXP, Inc. (BXP) and Federal Realty Investment Trust (FRT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.